Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofiâs Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Companyâs products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
髿é·
å瀟ã®åçã¯éå»3幎éã«ãããçå®ã«å¢å ããŠããã幎平åã§17.07%ã®æé·çã瀺ããŠããŸãã
é«ãå©çæé·
å瀟ã®çŽå©çã¯æ¥çããªãŒãããŠãããææ°ã®å¹ŽéçŽå©çã¯USD 52.67Bã§ãã
é«é
åœ
å瀟ã¯é«é
åœéæã§ãããææ°ã®é
åœæ§åã¯171.67%ã§ãã
å®å®é
åœ
å瀟ã¯éå»5幎éã«ãããç¶ç¶çã«é
åœã宿œããŠãããææ°ã®é
åœæ§åã¯171.67%ã§ãã
å²å®
åç€Ÿã®ææ°ã®PEã¯12.06ã§ãéå»3幎éã®æ°Žæºãšæ¯èŒããŠå®å€åã«ãããŸãã
æ©é¢æè³å®¶ã®å£²ãè¶ã
ææ°ã®æ©é¢æè³å®¶ã®ä¿ææ ªæ°ã¯225.52Mæ ªã§ãåååææ¯ã§13.87%æžå°ããŠããŸãã
ãµã©ã»ã±ã¿ã©ãŒãä¿æ
ã¹ã¿ãŒæè³å®¶ãµã©ã»ã±ã¿ã©ãŒã¯æ¬éæã9.63Mæ ªä¿æããŠããŸãã
åžå ޿޻åãæŽ»çº
å瀟ãžã®æè³å®¶ã®é¢å¿ãé«ãŸã£ãŠããã20æ¥éã®å£²è²·å転çã¯0.46ã§ãã